Literature DB >> 22734994

Repair of prosthetic mitral valve paravalvular leak using an off-pump transapical approach.

Vinod H Thourani1, Colleen M Smith, Robert A Guyton, Peter Block, David Liff, Patrick Willis, Stamatios Lerakis, Chesnal D Arepalli, Sharon Howell, Bryon J Boulton, James Stewart, Vasilis Babaliaros.   

Abstract

Patients who present with significant paravalvular regurgitation after mitral valve replacement remain a difficult patient population and high-risk surgical candidates. We present 3 cases of transapical closure of mitral valve paravalvular leak (PVL) after mitral valve replacement using Amplatzer closure devices (AGA Medical Corp, Plymouth, MN). All 3 patients experienced decreased regurgitation at the site of the closure as well as symptomatic improvement in their heart failure.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22734994     DOI: 10.1016/j.athoracsur.2011.12.035

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Off-pump transapical closure of a mitral periprosthetic leak: a new approach to a difficult problem.

Authors:  Diego Felipe Gaia; João Roberto Breda; Claudio Henrique Fischer; José Honório Palma
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-08-30

2.  Closure of a Prosthetic Mitral Valve Paravalvular Leak Using a Ventricular Septal Defect (VSD) Amplatzer Occluder Device.

Authors:  Oreoluwa Oladiran; Gabriel Areoye; Adeolu O Oladunjoye; Olubunmi O Oladunjoye; Eric Elgin; Anthony Licata
Journal:  Am J Case Rep       Date:  2021-01-30

3.  A Comparison of the Catheter-Based Transapical and Surgical Treatment Modalities for Mitral Paravalvular Leak.

Authors:  Aleksejus Zorinas; Vilius Janušauskas; Donatas Austys; Giedrius Davidavičius; Lina Puodžiukaitė; Diana Zakarkaitė; Robertas Stasys Samalavičius; Karolis Urbonas; Rita Kramena; Eustaquio Maria Onorato; Kęstutis Ručinskas
Journal:  J Clin Med       Date:  2022-08-25       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.